Prostatype Genomics recruits Steven Gaal as President of Prostatype Genomics Inc., USA
Prostatype Genomics AB has recruited Steven Gaal to the role of President of the company's wholly owned subsidiary, Prostatype Genomics Inc. Steven's task will be to establish and launch Prostatype®, the company's genomic test to assess the aggressiveness of prostate cancer in individual patients, in the US market. Steven has over 18 years of experience from leading positions in the sale of cancer diagnostic tools and services and begins his employment with Prostatype Genomics Inc. effective immediately.Steven comes to Prostatype Genomics Inc. with extensive experience in genomic testing.